---
schema_version: "secwatch.filing_event.v1"
accession: "0001398733-25-000018"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:30:59.906915+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Aquestive presents at H.C. Wainwright conference; no material updates disclosed

## Summary
- Investor presentation furnished as Exhibit 99.1; only cover slide text included in filing.
- No financial results, pipeline data, or guidance changes provided in the 8-K.
- Filing is a routine Regulation FD disclosure for a conference presentation.
- No specific numbers, names, or events beyond the presentation's existence.

## SEC filing metadata
- accession: 0001398733-25-000018
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000139873325000018/0001398733-25-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000139873325000018/aqst-20250908.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001398733-25-000018
- JSON: https://secwatch.observer/filing/0001398733-25-000018.json
- Plain text: https://secwatch.observer/filing/0001398733-25-000018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.